Myopia, commonly called nearsightedness, is a vision condition where close objects appear clear, but distant objects appear blurry. It occurs when the eye grows too long from front to back (axial length) or when the cornea is too curved, causing light to focus in front of the retina instead of directly on it.
Myopia is caused by a combination of genetics and environment:
Genetic factors
Environmental factors
Family history of myopia
High screen exposure in childhood
Minimal outdoor activity
Early onset of myopia (before age 8)
Urban living environments
Intensive academic demands
Myopia is not just a vision issue — it is a progressive eye health condition. As myopia increases, so does the risk of long-term eye disease.
High or progressive myopia significantly increases the risk of:
The higher the prescription, the greater the lifetime risk.
Myopia cannot always be prevented, but its progression can often be slowed with early intervention and proper management.
Protective strategies include:
Modern optometry now focuses on myopia management, not just vision correction.
MiSight® 1 day contact lenses are FDA-approved soft contact lenses designed specifically to slow myopia progression in children.
How MiSight works:
MiSight lenses use peripheral defocus technology, which changes how light focuses on the retina to slow eye growth.
Benefits:
Essilor Stellest® lenses are specialized myopia control glasses using Highly Aspherical Lenslet (HALT) technology.
How Stellest works:
They create a volume of defocused light signals that slow axial eye growth while maintaining clear central vision.
Benefits:
Ortho-K uses custom-designed rigid contact lenses worn overnight to gently reshape the cornea.
How Ortho-K works:
Benefits:
Low-dose atropine eye drops are used nightly to slow myopia progression.
How atropine works:
Atropine reduces biochemical signals that stimulate eye elongation.
Benefits:
The earlier treatment starts, the better the outcome. Myopia management is most effective when initiated:
Monitoring typically includes:
Yes. Myopia management treatments are clinically studied, evidence-based, and widely used in pediatric eye care.
Most myopia control treatments are considered elective or preventive care and may not be covered by standard vision insurance. Some plans may provide partial coverage for exams or materials.
Because every diopter matters. Lower prescriptions = lower lifetime risk of vision-threatening complications.
Myopia management is about protecting long-term eye health, not just improving vision today.
Myopia is a progressive eye disease that requires proactive management. Modern treatments like MiSight®, Stellest®, Ortho-K, and atropine therapy allow optometrists to slow progression, reduce long-term risks, and protect lifelong vision.
Early detection + early treatment = better lifelong outcomes.
Our doctors at Friedman Optometry are certified to manage myopia with all of the above methods. Ask your doctor which method is ideal for your child’s ocular health and development.